Op-Eds
Lives for Votes
December 15, 2005 — With his record, a call from state Attorney General Eliot Spitzer is enough to give even innocent defendants…
Op-Eds
Good Drugs, Bad Rap
These are turbulent times for the pharmaceutical industry and for its regulator, the FDA. Lately, both have focused increasingly on issues of safety.
Op-Eds
Point, Counterpoint: Wal-Mart on DVD
Documentary film has long been mired in debates about objectivity. Once strived for amongst serious documentarians, the notion of an objective documentary slowly degraded as…
Op-Eds
The Long REACH of the EU
The European Union's Council of Ministers is expected to vote soon on the proposed chemicals regulation called REACH, an acronym for Registration, Evaluation, and…
Op-Eds
Who Is Watching the Watchdog?
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Today in the D.C. Circuit Court of Appeals, outspoken hedge fund manager…
Op-Eds
Corporate Social Concerns: Are They Good Citizenship, Or a Rip-Off for Investors?
Fred Smith debates CSR in The Wall Street Journal…